CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: Possible Role of Roflumilast in Diabetic Nephropathy [Phase 3]
Summary
A Phase 3 clinical trial is investigating the possible role of roflumilast in diabetic nephropathy; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Diabetic Nephropathies | Phase 3 | Status: UNKNOWN